Healthcare Provider Information
Zydus Pharmaceuticals (USA) Inc. appreciates your interest in our product and we have included this information to assist you in managing your patient’s anticoagulation therapy.
Indications of Zydus Warfarin Sodium Tablets, USP
Indicated for prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE).
Indicated for prophylaxis and treatment of thromboembolic complications associated with atrial fibrilation (AF) and/or cardiac valve replacement.
Indicated to reduce the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
Results of Zydus' bioequivalencey study:
Warfarin Tablet Identifacton Chart
This tablet identification chart is a helpful comparison chart which shows Zydus Warfarin Sodium Tablets, USP have similar colored tablets to Coumadin® and other generic warfarin sodium tablets in all 9 strengths.